Streamlined production of nanoparticles for optimized drug delivery

Phosphorex Inc. – a contract development and manufacturing organization specializing in the production of particle-based formulations – is using the Automated Nanoparticle (ANP) System from Particle Works to optimize its processes.


Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Dr Julia Rashba-Step, VP of R&D and Alliance Management at Phosphorex, commented: “We help our clients with the development of nanomedicines by creating novel nanoparticles customized to individual project needs. Clients reach out to us at different stages of product development; some may need assistance in the early discovery phase while others already have a working formulation that they want to scale up. Our focus lies on process optimization, investigating different microfluidic parameters to achieve the ideal particle size, shape and structure, as well as improve targeting and drug encapsulation. The processes that we design must be robust and scalable and we therefore spent a significant amount of time searching for the optimal microfluidic system, choosing the ANP System from Particle Works.”

Julia continued: “The ANP System allows us to screen multiple formulations very quickly to achieve the target particle size and distribution; it is stable and ensures high consistency and reproducibility. The technology is easy to use and we’re so happy with the system that we have decided to act as a demonstration lab for Particle Works, offering training and technical support to help customers to advance their nanoparticle programs from proof-of-concept to the clinical development stage. The Particle Works team always listens to us, and works tirelessly to provide what we need. We enjoy working with them.”

Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours